Roche Diabetes Care Inc.
Indianapolis, IN Doing business as Roche Diabetes Care Inc. Roche Diabetes Care Inc. Part of Foundation Medicine, Inc.
- UEI
- F6JDDN8L9JM4
- CAGE
- 7DZ31
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Foundation Medicine, Inc.
Parent
EHXPZ92G4AD1
- Roche Diabetes Care Inc. F6JDDN8L9JM4
-
Foundation Medicine, Inc.
Parent
EHXPZ92G4AD1
- SAM.gov registration date
- Physical address
- 9115 Hague Rd, Indianapolis, IN 46256, USA
- Website
- accu-chek.com
- Founded
- 1974
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Roche diabetes care, roche diabetes supplies, pimc, materials management | Indian Health Service | $250,000 | |
| FY 25 roche diabetes care BPA - medical supply | Indian Health Service | $244,000 | |
| BPA call roche diabetes care, INC. Off VA contract V797D-50597 for diabetic testing supplies for the phoenix indian… | Indian Health Service | $156,480 | |
| Diabetic testing supplies, pimc | Indian Health Service | $250,000 | |
| FY24 B5 roche reagents 11.01.23 - GV | Federal Medical Center Rochester | $24,756 |
About Roche Diabetes Care Inc.
Roche Diabetes Care Inc., a for-profit manufacturer headquartered in Indianapolis, Indiana, serves as an established federal supplier specializing in diabetes management products and in-vitro diagnostic testing materials. The company manufactures and distributes blood glucose monitors, test strips, lancets, control solutions, and related medical consumables to federal healthcare organizations. Registered in SAM.gov since May 14, 2015, Roche Diabetes Care Inc. holds a current GSA Federal Supply Schedule contract for In-Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII), positioning it as a key vendor for federal agencies requiring diagnostic testing supplies and diabetes care products.
Roche Diabetes Care Inc. has demonstrated consistent federal contracting performance across multiple healthcare agencies, with the Indian Health Service and the Department of Justice Bureau of Prisons as primary customers. The company has received numerous delivery orders and blanket purchase agreement calls totaling millions of dollars for the provision of diabetic testing supplies, reagents, laboratory materials, and related consumables. Specific deliverables have included Accu-Chek test strips, blood glucose meters, lancets, control solutions, and diagnostic reagents for in-vitro laboratory testing. Awards have been issued as firm fixed-price delivery orders, blanket purchase agreement calls, and purchase orders without set-aside designations, indicating open competition based on the company's GSA schedule pricing. The Indian Health Service has awarded the majority of Roche's federal contracts, supporting diabetes management programs and comprehensive healthcare services for American Indian and Alaska Native populations across facilities including the Phoenix Indian Medical Center and other IHS-operated medical centers nationwide. The Bureau of Prisons, through the Federal Medical Center Rochester in Minnesota with performance at the Castleton, Indiana location, has also consistently awarded delivery orders to Roche for laboratory reagents and diagnostic test materials to support inmate healthcare services. Contract values have ranged from approximately $10,000 to $750,000 per individual award, with cumulative volumes reflecting Roche's role as a substantial supplier within the federal healthcare procurement ecosystem.
Roche Diabetes Care Inc. currently holds two active blanket purchase agreements as prime contract indefinite delivery vehicles. The first BPA, awarded by the Indian Health Service on September 23, 2021, carries a ceiling value of $2,000,000 and extends through September 26, 2026, providing for the procurement of diabetic testing supplies to support IHS diabetes management and care programs serving Native American populations. This BPA operates under the GSA Federal Supply Schedule for In-Vitro Diagnostics, Reagents, and Test Kits and has generated multiple task orders for the Phoenix Indian Medical Center and other IHS facilities. The second BPA, awarded by the Indian Health Service on May 25, 2023, has a ceiling value of $1,660,063.56 and extends through May 14, 2026, specifically supporting outpatient diabetes supply procurement for IHS beneficiaries. Both blanket purchase agreements are single-award vehicles with no set-aside designations, reflecting Roche's competitive positioning on the GSA schedule. The BPAs enable the Indian Health Service to efficiently order diabetic testing supplies, meters, test strips, lancets, and related consumables on an as-needed basis while leveraging the pricing rates established under Roche's master GSA contract. These indefinite delivery vehicles have proven effective mechanisms for providing critical diabetes management resources to American Indian and Alaska Native communities through IHS healthcare delivery systems.
Contract vehicles
Quick answers
What is Roche Diabetes Care Inc.'s UEI?
Roche Diabetes Care Inc.'s Unique Entity ID (UEI) in SAM.gov is F6JDDN8L9JM4.
What is Roche Diabetes Care Inc.'s CAGE code?
Roche Diabetes Care Inc.'s CAGE code is 7DZ31.
What is Roche Diabetes Care Inc.'s primary NAICS code?
Roche Diabetes Care Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Where is Roche Diabetes Care Inc. located?
Roche Diabetes Care Inc.'s physical address in SAM.gov is 9115 Hague Rd, Indianapolis, IN 46256, USA.
Is Roche Diabetes Care Inc. registered in SAM.gov?
Yes. Roche Diabetes Care Inc.'s SAM.gov registration is active through May 28, 2027.
Who is Roche Diabetes Care Inc.'s parent company?
Roche Diabetes Care Inc. is part of Foundation Medicine, Inc.
Which contract vehicles does Roche Diabetes Care Inc. hold?
Roche Diabetes Care Inc. holds a place on 1 federal contract vehicle: FSS-65-VII.
What is Roche Diabetes Care Inc.'s most recent federal award?
Roche Diabetes Care Inc.'s most recent federal contract award is Roche diabetes care, roche diabetes supplies, pimc, materials management (75H71225F28007), from Indian Health Service, on August 7, 2025.
On GovTribe
See Roche Diabetes Care Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors